Designer drug analysis by forensic MALDI techniques

Applications | 2019 | BrukerInstrumentation
MALDI, MS Imaging, LC/MS, LC/Ultra-HRMS
Industries
Forensics
Manufacturer
Bruker

Significance of the topic


The emergence of new psychoactive substances such as NBOMes poses significant challenges for forensic laboratories due to their potency, low dose per blotter paper and chemical diversity. High-resolution mass spectrometry imaging enables rapid, spatially resolved identification of trace amounts of these designer drugs without extensive sample preparation.

Objectives and overview of the study


This study aimed to develop and optimize a workflow combining matrix-assisted laser desorption/ionization (MALDI), MALDI mass spectrometry imaging and magnetic resonance mass spectrometry (MRMS) to detect and map NBOMe derivatives on seized blotter papers. Seven blotter samples containing 25I-NBOMe and 25I-NBOH were evaluated for analytical performance and matrix application methods.

Methodology and instrumentation


Seven blotter papers were obtained from forensic authorities and mounted on stainless steel targets. Matrix deposition was tested using:
  • Direct spotting of CHCA solution (25 mg/mL) via automatic pipette (15 µL).
  • Spraying with an ESI-assisted sprayer (uniform droplet formation).
Four organic matrices (CHCA, DHB, sinapinic acid, TCNQ) at concentrations between 5 and 25 mg/mL were compared. Analyses were conducted on a 9.4 T Solarix MRMS (FT-ICR MS) equipped with a 355 nm smartbeam-II laser. Experiments ran in positive mode over m/z 200–1500, with 100 laser shots per pixel, 200 Hz frequency and 30 µm focus. Imaging resolution was 300 µm, data processed in FlexImaging 3.0.

Main results and discussion


  • LDI-MS enabled initial screening: m/z 428.072 (25I-NBOMe) detected in samples S1–S6; m/z 414.057 (25I-NBOH) only in sample S7; mass accuracy <3 ppm.
  • MALDI imaging with sprayer application yielded more homogeneous matrix coverage, enhancing ion signal (TIC m/z 414: 8.0×10^7) compared to pipette (5.7×10^7) and LDI alone (3.0×10^7).
  • Among tested matrices, CHCA at concentrations >10 mg/mL provided highest sensitivity and uniform spatial distribution of m/z 428, likely via optimal hydrogen-bond interactions.

Benefits and practical applications


The optimized MALDI/MALDI imaging MRMS workflow allows rapid, high-confidence identification of NBOMe compounds on blotter papers with minimal preparation. Spatial mapping aids in assessing dose uniformity and detecting compound distribution, supporting forensic investigations and quality control.

Future trends and applications


Further developments may focus on automation of matrix deposition, integration with ambient ionization techniques for real-time screening, expansion to multiplex detection of various NPS classes, and improved software analytics for quantitative imaging in forensic casework.

Conclusion


Coupling MALDI imaging with high-resolution MRMS and optimized matrix application delivers a powerful analytical platform for forensic screening of designer drugs on blotter papers, providing accurate identification, spatial resolution and operational efficiency.

Reference


  • Almeida CM, Pinto FE, Santos NA, Souza LM, Merlo BB, Thompson CJ, Romão W (2019) Designer drugs analysis by LDI(+), MALDI(+) and MALDI(+) Imaging coupled to FT-ICR MS. Microchemical Journal 149:104002. DOI:10.1016/j.microc.2019.104002.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Bruker MRMS Applications Handbook
Interrogation of the Spatial Metabolome of Ginkgo biloba with high-resolution MALDI and LDI Mass Spectrometry Imaging
ENHANCED MOLECULAR COVERAGE, RESOLUTION AND SPEED FOR IN-SITU PHARMACEUTICAL TABLET MSI ANALYSIS BY COMBINING DESI AND MALDI USING MULTI-REFLECTING Q-TOF
Pharmacokinetic study based on atmospheric pressure MALDI-IT-TOF imaging mass microscope: A case of octreotide in mouse target tissues